Guillemette Emma Benoist

4PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 21, 2020
The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients.

Guillemette E Benoist, Inge M van Oort, David M Burger

|Feb 01, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.

Guillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine

|Sep 08, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk

|Apr 04, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.

Guillemette E Benoist, Eric van der Meulen, Floor J E Lubberman

Pageof 1

Frequent Collaborators

2 joint publications

Niven Mehra

1 joint publications

Maarten J van der Doelen

1 joint publications

Rob Ter Heine

1 joint publications

Inge M van Oort